Pharmaceutical

IRA holds the scope to shape pharma’s research strategy, say experts

The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly.

Apr 10, 2025 - 06:00
IRA holds the scope to shape pharma’s research strategy, say experts
The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly.
Read the original article

Tags:

Previous Article

Merida launches with $121m to target autoimmune antibodies

Next Article

Beyond oncology: The expanding potential of cell and gene therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Rare disease treatments skipping UK patients largely due to costs, survey shows

Rare disease treatments skipping UK patients largely du...

Mar 1, 2025

STAT+: ‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J

STAT+: ‘True disruption’: Mark Cuban’s company will sel...

Apr 5, 2023

When did Wall Street sour on Lilly’s Alzheimer’s drug?

When did Wall Street sour on Lilly’s Alzheimer’s drug?

Mar 13, 2024